TENXTENAX THERAPEUTICS, INC.vs its industry peers
A metric-by-metric comparison of TENAX THERAPEUTICS, INC. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TENXThis | $68M#5 | — | 0.6x#3 | — | — | -198.9%#13 | — | -46.3%#6 | — | — | -74.3%#8 | — |
| PMVP | $74M#1 | — | 1.0x#5 | — | — | -32.0%#11 | — | -108.7%#10 | — | — | -0.7%#2 | — |
| MNOV | $71M#2 | — | 1.9x#7 | 173.0x#6 | — | 8.6%#7 | -3242.5%#7 | 32.2%#1 | — | — | -3.7%#4 | — |
| SDEV | $70M#3 | — | 0.4x#1 | 7.2x#5 | -6.4%#6 | -8632.9%#14 | -86.3%#5 | -346.3%#12 | -4.8%#1 | — | -81.5%#9 | 6.9%#1 |
| ACRV | $69M#4 | — | 0.8x#4 | — | — | 3.3%#9 | — | -89.9%#7 | — | — | -30.8%#6 | — |
| CING | $68M#6 | — | 2.9x#8 | — | — | -35.6%#12 | — | -95.7%#8 | — | — | 23.0%#1 | — |
| MAIA | $68M#7 | — | 3.3x#9 | — | — | 3.7%#8 | — | -108.3%#9 | — | — | -1.8%#3 | — |
| FBIO | — | 0.7x#1 | — | — | 9.7%#4 | 76.2%#4 | -111.0%#6 | 22.5%#2 | — | — | -21.3%#5 | — |
| EVFM | $63M#8 | — | — | 3.1x#3 | 4.2%#5 | 104.4%#2 | 16.7%#2 | — | — | — | — | — |
| CPIX | $63M#9 | — | 3.6x#10 | 1.4x#1 | 17.6%#3 | 56.2%#5 | -6.3%#3 | -16.3%#4 | — | — | — | — |
| TELO | $62M#10 | — | 12.4x#11 | — | — | 37.0%#6 | — | -206.9%#11 | — | — | — | — |
| SPRO | $61M#11 | 7.4x#2 | 1.4x#6 | 4.8x#4 | 3292.5%#1 | 112.5%#1 | 50.2%#1 | 19.4%#3 | — | — | -56.3%#7 | — |
| XBIT | $59M#12 | — | 0.5x#2 | — | -100.0%#7 | -18.2%#10 | — | -35.5%#5 | — | — | — | — |
| VRCA | $59M#13 | — | 13.6x#12 | 1.6x#2 | 370.2%#2 | 76.6%#3 | -34.2%#4 | -415.6%#13 | -36.1%#2 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice